On one hand, the analysis indicated that both HOXC13 and HOXD13 can be held as mutational cancer drivers in breast adenocarcinomas and esophageal tumors, respectively, highlighting their proliferation-inducing capacity. This evidence concerns the gene HOXD13 and breast adenocarcinoma.